Travere Therapeutics (TVTX) PT Raised to $50 at Wells Fargo
Tweet
Share
E-mailGet Alerts TVTX Hot Sheet
Price: $55.38 +0.49%
Rating Summary:
12 Buy, 2 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 4 | Down: 13 | New: 23
Rating Summary:
12 Buy, 2 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 4 | Down: 13 | New: 23
Join SI Premium – FREE
Wells Fargo analyst Mohit Bansal raised the price target on Travere Therapeutics (NASDAQ: TVTX) to $50.00 (from $40.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Take-Two Interactive (TTWO) PT Raised to $368 at BofA Securities
- ChargePoint Holdings Inc. (CHPT) PT Raised to $8 at UBS as Cost Discipline Improves
- Travere Therapeutics (TVTX) PT Raised to $61 at Wedbush
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
